Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02080819 · ClinicalTrials.gov registry record · Phase 2
Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse
A Phase 2 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 2
- Development phase
- 131
- Enrollment target
NCT02080819 is a Phase 2 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 131 participants.
The verdict
NCT02080819, a Phase 2 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 131 participants
- Enrollment target
Study Summary
This project proposes to investigate the role of brain connectivity in the mechanism of treatment response to dopaminergic medications in cocaine dependence.
Interventions
- DRUG levodopa/carbidopa 400/100 BID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-01-21 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02080819
The ClinicalTrials.gov registry entry for NCT02080819 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which levodopa/carbidopa 400/100 BID is the first listed.
NCT02080819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02080819 about?
NCT02080819 is a clinical study titled "Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse". This project proposes to investigate the role of brain connectivity in the mechanism of treatment response to dopaminergic medications in cocaine dependence.
What is the current status of trial NCT02080819?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 131 participants. The study started on 2014-02. Estimated completion is 2017-01-21.
What interventions are being tested in trial NCT02080819?
The interventions under investigation include: levodopa/carbidopa 400/100 BID (DRUG).
Who is sponsoring clinical trial NCT02080819?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.